Home » Topics » BioWorld Science

BioWorld Science
RSS

European Commission approves Stelara for moderate to severely active ulcerative colitis

Sep. 5, 2019

Tonix begins phase I study of TNX-601 for daytime treatment of PTSD

Sep. 5, 2019

First safety data presented from phase II trial of revacept

Sep. 5, 2019

Idera Pharmaceuticals and Abbvie to collaborate on immunooncology trial

Sep. 5, 2019

Optimized liver-directed gene therapy for Pompe's disease evaluated in vivo

Sep. 5, 2019

New CDK7 inhibitors presented by Ancureall Biomedical Technology (Shanghai)

Sep. 5, 2019

Chinese researchers describe BRD4 inhibitors

Sep. 5, 2019

Beijing Scitech-Mq Pharmaceuticals divulges VEGFR2 and MET inhibitors

Sep. 5, 2019

Medshine Discovery presents new ATR kinase inhibitors

Sep. 5, 2019

Ideaya Biosciences patents AhR modulators

Sep. 5, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...